Compare Jones Lang LaSalle Inc (JLL) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jones Lang LaSalle Inc vs TransMedics Group Inc — how do they compare? Jones Lang LaSalle Inc trades at $325.29 (market cap $15.12B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Jones Lang LaSalle Inc is far larger — about 6× TransMedics Group Inc's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| JLL | TMDX | |
|---|---|---|
Market Cap | $15.12B | $2.54B |
Sector | Real Estate | Technology |
52-Week High | $358.66 | $150.42 |
52-Week Low | $253.48 | $61.99 |
Enterprise Value | $18.66B | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
